• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

普遍的 SARS-CoV-2 入院筛查和人群发病率的平行动态。

Parallel dynamics in the yield of universal SARS-CoV-2 admission screening and population incidence.

机构信息

Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and University of Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.

Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

出版信息

Sci Rep. 2023 May 5;13(1):7296. doi: 10.1038/s41598-023-33824-6.

DOI:10.1038/s41598-023-33824-6
PMID:37147331
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10160732/
Abstract

The majority of SARS-CoV-2 transmissions originates from either asymptomatic or presymptomatic individuals. To prevent unnoticed introduction of SARS-CoV-2, many hospitals have implemented universal admission screening during the COVID-19 pandemic. The present study aimed to investigate associations between results of an universal SARS-CoV-2 admission screening and public SARS-CoV-2 incidence. Over a study period of 44 weeks, all patients admitted to a large tertiary care hospital were tested for SARS-CoV-2 by polymerase chain reaction. SARS-CoV-2 positive patients were retrospectively categorized as symptomatic or asymptomatic at admission. Cantonal data were used to calculate weekly incidence rates per 100,000 inhabitants. We used regression models for count data to assess the association of the weekly cantonal incidence rate and the proportion of positive SARS-CoV-2 tests in the canton with (a) the proportion of SARS-CoV-2 positive individuals and (b) the proportion of asymptomatic SARS-CoV-2 infected individuals identified in universal admission screening, respectively. In a 44-week period, a total of 21,508 admission screenings were performed. SARS-CoV-2 PCR was positive in 643 (3.0%) individuals. In 97 (15.0%) individuals, the positive PCR reflected residual viral replication after recent COVID-19, 469 (72.9%) individuals had COVID-19 symptoms and 77 (12.0%) SARS-CoV-2 positive individuals were asymptomatic. Cantonal incidence correlated with the proportion of SARS-CoV-2 positive individuals [rate ratio (RR): 2.03 per 100 point increase of weekly incidence rate, 95%CI 1.92-2.14] and the proportion of asymptomatic SARS-CoV-2 positive individuals (RR: 2.40 per 100 point increase of weekly incidence rate, 95%CI 2.03-2.82). The highest correlation between dynamics in cantonal incidence and results of admission screening was observed at a lag time of one week. Similarly, the proportion of positive SARS-CoV-2 tests in the canton of Zurich correlated with the proportion of SARS-CoV-2 positive individuals (RR: 2.86 per log increase in the proportion of positive SARS-CoV-2 tests in the canton, 95%CI 2.56-3.19) and the proportion of asymptomatic SARS-CoV-2 positive individuals (RR: 6.50 per log increase in the proportion of positive SARS-CoV-2 tests in the canton, 95%CI 3.93-10.75) in admission screening. Around 0.36% of admission screenings were positive in asymptomatic patients. Admission screening results paralleled changes in population incidence with a brief lag.

摘要

大多数 SARS-CoV-2 的传播源自无症状或症状前个体。为防止 SARS-CoV-2 被忽视地传入,许多医院在 COVID-19 大流行期间实施了普遍入院筛查。本研究旨在调查普遍 SARS-CoV-2 入院筛查结果与公众 SARS-CoV-2 发病率之间的关联。在 44 周的研究期间,对一家大型三级保健医院的所有入院患者均采用聚合酶链反应进行 SARS-CoV-2 检测。将 SARS-CoV-2 阳性患者在入院时分为有症状或无症状。使用州数据计算每 10 万人的每周发病率。我们使用计数数据的回归模型来评估每周州发病率和州内 SARS-CoV-2 检测阳性比例与 (a) SARS-CoV-2 阳性个体比例和 (b) 普遍入院筛查中无症状 SARS-CoV-2 感染者比例之间的关联。在 44 周期间,共进行了 21508 次入院筛查。SARS-CoV-2 PCR 阳性 643 人(3.0%)。在 97 例(15.0%)中,阳性 PCR 反映了近期 COVID-19 后残留的病毒复制,469 例(72.9%)患者有 COVID-19 症状,77 例(12.0%)SARS-CoV-2 阳性患者无症状。州发病率与 SARS-CoV-2 阳性个体比例相关(率比(RR):每周发病率增加 100 点,RR:2.03,95%CI 1.92-2.14)和无症状 SARS-CoV-2 阳性个体比例(RR:每周发病率增加 100 点,RR:2.40,95%CI 2.03-2.82)。在滞后一周时,州发病率动态与入院筛查结果之间的相关性最高。同样,苏黎世州的 SARS-CoV-2 检测阳性比例与 SARS-CoV-2 阳性个体比例(RR:苏黎世州 SARS-CoV-2 检测阳性比例每增加 1 个对数,RR:2.86,95%CI 2.56-3.19)和无症状 SARS-CoV-2 阳性个体比例(RR:苏黎世州 SARS-CoV-2 检测阳性比例每增加 1 个对数,RR:6.50,95%CI 3.93-10.75)相关。在无症状患者中,约有 0.36%的入院筛查呈阳性。入院筛查结果与人群发病率的变化相平行,略有滞后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fec/10163053/4e870bb0b7aa/41598_2023_33824_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fec/10163053/4e2588232829/41598_2023_33824_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fec/10163053/4e870bb0b7aa/41598_2023_33824_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fec/10163053/4e2588232829/41598_2023_33824_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fec/10163053/4e870bb0b7aa/41598_2023_33824_Fig2_HTML.jpg

相似文献

1
Parallel dynamics in the yield of universal SARS-CoV-2 admission screening and population incidence.普遍的 SARS-CoV-2 入院筛查和人群发病率的平行动态。
Sci Rep. 2023 May 5;13(1):7296. doi: 10.1038/s41598-023-33824-6.
2
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益(CoV-Surv 研究):一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.
3
Universal Polymerase Chain Reaction Screening for Severe Acute Respiratory Syndrome Coronavirus 2 in Asymptomatic Patients Before Hospital Admission in Tokyo, Japan.日本东京无症状住院患者的严重急性呼吸综合征冠状病毒 2 的通用聚合酶链反应筛查。
J Clin Virol. 2021 Sep;142:104915. doi: 10.1016/j.jcv.2021.104915. Epub 2021 Jul 15.
4
Pitfall of Universal Pre-Admission Screening for SARS-CoV-2 in a Low Prevalence Country.在低流行率国家对严重急性呼吸综合征冠状病毒2进行普遍入院前筛查的陷阱。
Viruses. 2021 Apr 30;13(5):804. doi: 10.3390/v13050804.
5
Universal Admission Screening for SARS-CoV-2 Infections among Hospitalized Patients, Switzerland, 2020.瑞士 2020 年对住院患者进行的 SARS-CoV-2 感染普遍筛查。
Emerg Infect Dis. 2021 Feb;27(2):404-410. doi: 10.3201/eid2702.202318. Epub 2021 Jan 4.
6
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
7
Screening Testing for SARS-CoV-2 upon Admission to Rehabilitation Hospitals in a High COVID-19 Prevalence Community.高 COVID-19 流行地区康复医院入院时对 SARS-CoV-2 的筛查检测。
PM R. 2020 Oct;12(10):1009-1014. doi: 10.1002/pmrj.12454. Epub 2020 Aug 31.
8
Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.BNT162b2 疫苗接种与医护人员中出现有症状和无症状 SARS-CoV-2 感染的相关性。
JAMA. 2021 Jun 22;325(24):2457-2465. doi: 10.1001/jama.2021.7152.
9
Universal screening for SARS-CoV-2 before labor admission during Covid-19 pandemic in Madrid.马德里在 COVID-19 大流行期间对临产孕妇进行 SARS-CoV-2 普筛
J Perinat Med. 2020 Nov 26;48(9):981-984. doi: 10.1515/jpm-2020-0236.
10
Early Adoption of Longitudinal Surveillance for SARS-CoV-2 among Staff in Long-Term Care Facilities: Prevalence, Virologic and Sequence Analysis.长期护理机构工作人员中对 SARS-CoV-2 进行纵向监测的早期采用:患病率、病毒学和序列分析。
Microbiol Spectr. 2021 Dec 22;9(3):e0100321. doi: 10.1128/Spectrum.01003-21. Epub 2021 Nov 10.

引用本文的文献

1
General SIR model for visible and hidden epidemic dynamics.用于可见和隐藏疫情动态的一般SIR模型。
Front Artif Intell. 2025 Feb 24;8:1559880. doi: 10.3389/frai.2025.1559880. eCollection 2025.
2
Trends of the COVID-19 dynamics in 2022 and 2023 vs. the population age, testing and vaccination levels.2022年和2023年新冠疫情动态与人口年龄、检测及疫苗接种水平的趋势对比。
Front Big Data. 2024 Jan 10;6:1355080. doi: 10.3389/fdata.2023.1355080. eCollection 2023.

本文引用的文献

1
Pitfall of Universal Pre-Admission Screening for SARS-CoV-2 in a Low Prevalence Country.在低流行率国家对严重急性呼吸综合征冠状病毒2进行普遍入院前筛查的陷阱。
Viruses. 2021 Apr 30;13(5):804. doi: 10.3390/v13050804.
2
High Efficacy of Saliva in Detecting SARS-CoV-2 by RT-PCR in Adults and Children.唾液在成人和儿童中通过逆转录聚合酶链反应检测严重急性呼吸综合征冠状病毒2的高效性。
Microorganisms. 2021 Mar 19;9(3):642. doi: 10.3390/microorganisms9030642.
3
Continued proportional age shift of confirmed positive COVID-19 incidence over time to children and young adults: Washington State March-August 2020.
确诊 COVID-19 发病率随时间推移持续向儿童和青年转移:华盛顿州 2020 年 3 月至 8 月。
PLoS One. 2021 Mar 24;16(3):e0243042. doi: 10.1371/journal.pone.0243042. eCollection 2021.
4
Systematic screening on admission for SARS-CoV-2 to detect asymptomatic infections.入院时对 SARS-CoV-2 的系统性筛查,以检测无症状感染。
Antimicrob Resist Infect Control. 2021 Feb 27;10(1):44. doi: 10.1186/s13756-021-00912-z.
5
The role of asymptomatic and pre-symptomatic infection in SARS-CoV-2 transmission-a living systematic review.无症状和症状前感染在 SARS-CoV-2 传播中的作用——一项实时系统评价。
Clin Microbiol Infect. 2021 Apr;27(4):511-519. doi: 10.1016/j.cmi.2021.01.011. Epub 2021 Jan 21.
6
SARS-CoV-2 Transmission From People Without COVID-19 Symptoms.SARS-CoV-2 从无 COVID-19 症状者传播。
JAMA Netw Open. 2021 Jan 4;4(1):e2035057. doi: 10.1001/jamanetworkopen.2020.35057.
7
Universal Admission Screening for SARS-CoV-2 Infections among Hospitalized Patients, Switzerland, 2020.瑞士 2020 年对住院患者进行的 SARS-CoV-2 感染普遍筛查。
Emerg Infect Dis. 2021 Feb;27(2):404-410. doi: 10.3201/eid2702.202318. Epub 2021 Jan 4.
8
Performance and feasibility of universal PCR admission screening for SARS-CoV-2 in a German tertiary care hospital.德国一家三级保健医院中用于 SARS-CoV-2 的通用 PCR 入院筛查的性能和可行性。
J Med Virol. 2021 May;93(5):2890-2898. doi: 10.1002/jmv.26770. Epub 2021 Feb 15.
9
Analysis of SARS-CoV-2 Transmission in Different Settings, Brunei.对文莱不同环境中 SARS-CoV-2 传播的分析。
Emerg Infect Dis. 2020 Nov;26(11):2598-2606. doi: 10.3201/eid2611.202263. Epub 2020 Oct 9.
10
Changing Age Distribution of the COVID-19 Pandemic - United States, May-August 2020.新冠疫情年龄分布变化 - 美国,2020 年 5 月至 8 月。
MMWR Morb Mortal Wkly Rep. 2020 Oct 2;69(39):1404-1409. doi: 10.15585/mmwr.mm6939e1.